Jason P Rhodes $DYN SEC Form 4 Insider Trading

Jason P Rhodes has filed a total of 109 insider trades in $DYN since 2021. Their most recent trade was a sale of 62,543 shares, made on Jul 07, 2026. Their largest trade was a purchase of 934,581 shares, made on Dec 12, 2022. We estimate that they now own 4.1 million shares of $DYN, worth an estimated $96.3 million.

Insider Trading at $DYN

There have been a total of 450 insider trades reported at $DYN since 2021, with 3.7 million shares purchased and 13.3 million shares sold. The most active insider traders in $DYN stock have been Oxana Beskrovnaya, Susanna Gatti High, and Richard William Scalzo. The most recent trade was a sale of 62,543 shares reported by Jason P Rhodes (None), made on Jul 07, 2026.

$DYN Executives and Stock Owners with Insider Trades

• Oxana Beskrovnaya, Chief Scientific Officer

• Susanna Gatti High, Chief Operating Officer

• Richard William Scalzo, SVP, Head of Finance & Admin.

• Jonathan Mcneill, Chief Business Officer

• Wildon Farwell, Chief Medical Officer

• Joshua T Brumm, CEO & President

• John Cox, CEO & President

• Joshua T Brumm, See Remarks

• Richard William Scalzo, See Remarks

• Jonathan Mcneill, See Remarks

• Douglas Kerr, Chief Medical Officer

• Johanna Friedl-Naderer, Chief Commercial Officer

• Erick Lucera, Chief Financial Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.